A detailed history of Sowell Financial Services LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Sowell Financial Services LLC holds 71,967 shares of RXRX stock, worth $297,943. This represents 0.01% of its overall portfolio holdings.

Number of Shares
71,967
Previous 54,667 31.65%
Holding current value
$297,943
Previous $266,000 11.65%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 20, 2026

BUY
$4.14 - $6.79 $71,622 - $117,467
17,300 Added 31.65%
71,967 $297,000
Q3 2025

Oct 17, 2025

BUY
$4.52 - $6.54 $247,094 - $357,522
54,667 New
54,667 $266,000

Others Institutions Holding RXRX

About RECURSION PHARMACEUTICALS, INC.


  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $747M
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Sowell Financial Services LLC Portfolio

Follow Sowell Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sowell Financial Services LLC with notifications on news.